<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id><journal-id journal-id-type="publisher-id">OMCL</journal-id><journal-title-group><journal-title>Oxidative Medicine and Cellular Longevity</journal-title></journal-title-group><issn pub-type="ppub">1942-0900</issn><issn pub-type="epub">1942-0994</issn><publisher><publisher-name>Hindawi</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5494101</article-id><article-id pub-id-type="doi">10.1155/2017/7921363</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>High-Intensity Exercise Reduces Cardiac Fibrosis and Hypertrophy but Does Not Restore the Nitroso-Redox Imbalance in Diabetic Cardiomyopathy</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Novoa</surname><given-names>Ulises</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Arauna</surname><given-names>Diego</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Moran</surname><given-names>Marisol</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Nu&#x000f1;ez</surname><given-names>Madelaine</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zagmutt</surname><given-names>Sebasti&#x000e1;n</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Saldivia</surname><given-names>Sergio</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Valdes</surname><given-names>Cristian</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Villase&#x000f1;or</surname><given-names>Jorge</given-names></name><xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Zambrano</surname><given-names>Carmen Gloria</given-names></name><xref ref-type="aff" rid="I3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-3437-8998</contrib-id><name><surname>Gonzalez</surname><given-names>Daniel R.</given-names></name><xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib></contrib-group><aff id="I1"><sup>1</sup>Department of Basic Biomedical Sciences, Faculty of Health Sciences, Universidad de Talca, Talca, Chile</aff><aff id="I2"><sup>2</sup>Institute for Chemistry of Natural Resources, Universidad de Talca, Talca, Chile</aff><aff id="I3"><sup>3</sup>Department of Human Movement Sciences, Faculty of Health Sciences, Universidad de Talca, Talca, Chile</aff><author-notes><corresp id="cor1">*Daniel R. Gonzalez: <email>dagonzalez@utalca.cl</email></corresp><fn fn-type="other"><p>Academic Editor: Patricia C. Brum</p></fn></author-notes><pub-date pub-type="ppub"><year>2017</year></pub-date><pub-date pub-type="epub"><day>18</day><month>6</month><year>2017</year></pub-date><volume>2017</volume><elocation-id>7921363</elocation-id><history><date date-type="received"><day>10</day><month>2</month><year>2017</year></date><date date-type="rev-recd"><day>18</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>27</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2017 Ulises Novoa et al.</copyright-statement><copyright-year>2017</copyright-year><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Diabetic cardiomyopathy refers to the manifestations in the heart as a result of altered glucose homeostasis, reflected as fibrosis, cellular hypertrophy, increased oxidative stress, and apoptosis, leading to ventricular dysfunction. Since physical exercise has been indicated as cardioprotective, we tested the hypothesis that high-intensity exercise training could reverse the cardiac maladaptations produced by diabetes. For this, diabetes was induced in rats by a single dose of alloxan. Diabetic rats were randomly assigned to a sedentary group or submitted to a program of exercise on a treadmill for 4 weeks at 80% of maximal performance. Another group of normoglycemic rats was used as control. Diabetic rat hearts presented cardiomyocyte hypertrophy and interstitial fibrosis. Chronic exercise reduced both parameters but increased apoptosis. Diabetes increased the myocardial levels of the mRNA and proteins of NADPH oxidases NOX2 and NOX4. These altered levels were not reduced by exercise. Diabetes also increased the level of uncoupled endothelial nitric oxide synthase (eNOS) that was not reversed by exercise. Finally, diabetic rats showed a lower degree of phosphorylated phospholamban and reduced levels of SERCA2 that were not restored by high-intensity exercise. These results suggest that high-intensity chronic exercise was able to reverse remodeling in the diabetic heart but was unable to restore the nitroso-redox imbalance imposed by diabetes.</p></abstract><funding-group><award-group><funding-source>Program of Excellence Interdisciplinary Research QuimBio Universidad de Talca</funding-source></award-group><award-group><funding-source>Fondo Nacional de Desarrollo Cient&#x000ed;fico y Tecnol&#x000f3;gico</funding-source><award-id>1150662</award-id></award-group></funding-group></article-meta></front><body><sec id="sec1"><title>1. Introduction</title><p>Diabetes mellitus is one of the most common chronic diseases all over the world, becoming an epidemic, triggered probably by reduced physical activity and increased obesity in the population [<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>]. Diabetic cardiomyopathy is the deterioration of the myocardial function and morphology produced by the altered glucose homeostasis imposed in diabetes, independent of coronary disease [<xref rid="B3" ref-type="bibr">3</xref>]. Diabetic cardiomyopathy is characterized initially by diastolic dysfunction and cardiac hypertrophy, with preserved ejection fraction. At the cellular level, the diabetic myocardium presents myocyte hypertrophy, interstitial fibrosis, and apoptosis [<xref rid="B4" ref-type="bibr">4</xref>]. This process of cardiac deterioration involves the generation of reactive oxidative species (ROS) [<xref rid="B5" ref-type="bibr">5</xref>]. Oxidative stress exists when the production of ROS outweighs their degradation by antioxidant systems [<xref rid="B6" ref-type="bibr">6</xref>]. The resultant elevation of ROS has numerous harmful effects on the cardiovascular system via cellular damage by oxidation, disruption of vascular homeostasis through interference with NO, and detrimental intracellular signaling pathways [<xref rid="B7" ref-type="bibr">7</xref>]. In a variety of animal models of diabetes and humans with diabetic cardiomyopathy, there is excessive ROS production from both mitochondrial and extramitochondrial sources, and ROS have been implicated in all stages of the development of heart failure, from cardiac hypertrophy to fibrosis, contractile dysfunction, and failure [<xref rid="B5" ref-type="bibr">5</xref>, <xref rid="B8" ref-type="bibr">8</xref>].</p><p>Several ROS sources contribute to the observed oxidative stress in the diabetic heart such as xanthine oxidoreductase (XOR) [<xref rid="B9" ref-type="bibr">9</xref>], nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOX) [<xref rid="B10" ref-type="bibr">10</xref>], mitochondria [<xref rid="B9" ref-type="bibr">9</xref>], and uncoupled nitric oxide synthases (NOS) [<xref rid="B10" ref-type="bibr">10</xref>&#x02013;<xref rid="B13" ref-type="bibr">13</xref>].</p><p>A direct consequence of the increased production of reactive oxygen species (ROS) is NOS uncoupling. This is the aftermath of the oxidation of tetrahydrobiopterin (BH<sub>4</sub>), an essential cofactor for NOS activity. When NOS is uncoupled, its activity is redirected towards the production of superoxide, instead of nitric oxide (NO), further contributing to the oxidative process.</p><p>Physical exercise is prescribed as part of the rehabilitation for patients with heart diseases since it reduces cardiac risk factors, protects against myocardial damage, and improves cardiac function [<xref rid="B14" ref-type="bibr">14</xref>]. In type 2 diabetic patients, exercise is also advised as part of the nonpharmacological treatment, since it exerts a number of benefits such as improved insulin sensitivity and reduction in body weight [<xref rid="B15" ref-type="bibr">15</xref>]. Nevertheless, there is less information regarding type 1 diabetic patients. A recent report indicates that intense exercise is associated to reduction in the risk of cardiovascular events in type 1 diabetes patients [<xref rid="B16" ref-type="bibr">16</xref>]. In animal models of type 1 diabetes, low-to-moderate exercise training has been found to improve cardiac glucose metabolism [<xref rid="B17" ref-type="bibr">17</xref>], reduce apoptosis [<xref rid="B18" ref-type="bibr">18</xref>], and improve ventricular function [<xref rid="B19" ref-type="bibr">19</xref>].</p><p>The intensity of exercise for diabetic patients is a matter of intense investigation, being suggested that in particular, high-intensity interval training may confer additional cardiometabolic protection [<xref rid="B20" ref-type="bibr">20</xref>]. For instance, while moderate-intensity exercise did not improved cardiac function in type 2 diabetic patients [<xref rid="B21" ref-type="bibr">21</xref>], a similar study but with a high-intensity interval training showed improved cardiac function and remodeling [<xref rid="B22" ref-type="bibr">22</xref>]. Another study showed no difference between moderate- and high-intensity exercises [<xref rid="B23" ref-type="bibr">23</xref>], although this later did not include the assessment of cardiac parameters.</p><p>As mentioned before, in animal models of type 1 diabetes, low- and moderate-intensity exercise have been reported to reverse or prevent some of the cardiac maladaptations of diabetic cardiomyopathy [<xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B24" ref-type="bibr">24</xref>]. Nevertheless, the information regarding high-intensity exercise in diabetic cardiomyopathy is less abundant.</p><p>The mechanisms by which exercise may produce it beneficial effects include an increase in nitric oxide production [<xref rid="B25" ref-type="bibr">25</xref>] and a reduction in oxidative stress [<xref rid="B26" ref-type="bibr">26</xref>]. In this work, we tested the hypothesis that a high-intensity exercise training program could reverse the cardiac maladaptations and oxidative stress that are produced by diabetes.</p></sec><sec id="sec2"><title>2. Methods</title><sec id="sec2.1"><title>2.1. Animals and Training Protocol</title><p>Diabetes was induced in 3-month-old male Sprague&#x02013;Dawley rats by a single dose of alloxan (Sigma-Aldrich, St. Louis, MO), 200&#x02009;mg/kg, intraperitoneal. Six days day after alloxan injection, hyperglycemia was confirmed (plasma glucose levels &#x0003e;300&#x02009;mg/dL). Diabetic rats were randomly assigned to a sedentary group (<italic>n</italic> = 5) or submitted to a program of exercise on a motor-driven treadmill, 5 days/week, for 4 weeks. The maximal intensity of the training for each rat was assessed by stepwise increases in the treadmill speed. Two days prior to the test, the animals were submitted to a period of acclimatization in the treadmill, walking at 0.6&#x02009;km/h, twice a day, the first day. During the second and third days, the incremental velocity test was applied that consisted of increasing the treadmill velocity from 0.6&#x02009;km/h to 0.2&#x02009;km/h every 3&#x02009;min, with no upper limit, until the animal reached exhaustion that defines the end of the test. The angle of the treadmill was kept constant at 0&#x000b0;. Once the animal reached its maximal velocity for at least 3 minutes, this value was assigned as the maximal performance (100%). Then, the animal was trained at the 80% of its capacity (velocity and time), once a day, five days a week, for four weeks. Every week, maximal capacity was reevaluated for each animal, to adjust its training load for the next week.</p><p>To determine the duration (in minutes) of the training, a tolerance test was applied that consisted in determining the maximal time that the rat was able to sustain the 80% of the velocity previously determined. Finally, the training consisted of the 80% of the maximal velocity for the 80% of maximal time. This finally determines the volume of training for each animal. The rats were maintained in the animal facility of the Universidad de Talca, with food and water ad libitum, at room temperature (22&#x02009;&#x000b1;&#x02009;5&#x000b0;C) and with cycles of 12&#x02009;hrs light/darkness. The diet used was obtained from Champion&#x000ae; (20.5% crude protein, 5% fiber, 4% fat). A group of normoglycemic rats was used as control (<italic>n</italic> = 7). Finally, the rats were euthanized after two days after the training protocol finished, to avoid potential confounding effects of acute exercise. To extract the heart, the animals were induced deep anesthesia with ketamine (75&#x02009;mg/100&#x02009;g body weight) and xylazine (15&#x02009;mg/100&#x02009;g body weight), checking for the complete absence of sensitive reflexes.</p><p>Plasma glucose determinations were performed using the glucose oxidase system (Valtek Diagnostics, Santiago, Chile), following the manufacturer instructions, and using a spectrophotometer (Rayleigh UV-9200).</p><p>All procedures were performed in conform to the <italic>NIH Guide for the Care and Use of Laboratory Animals</italic>. The protocol was approved by the Bioethical Committee of the Universidad de Talca.</p></sec><sec id="sec2.2"><title>2.2. Histological Staining</title><p>After excision, hearts were fixed in 4% paraformaldehyde. After fixation, the samples underwent a series of dehydrations and were embedded in paraffin blocks. After this, 5&#x02009;<italic>&#x003bc;</italic>m sections were obtained with a Microm HM 325 microtome and then mounted on xylanized slides. Sections of hydrated and deparaffinized xylene tissue were stained with hematoxylin and eosin (H&#x00026;E), used for TUNEL analysis or Sirius red staining.</p></sec><sec id="sec2.3"><title>2.3. Assessment of Cardiac Apoptosis</title><p>Apoptosis was evaluated by the TUNEL assay [<xref rid="B27" ref-type="bibr">27</xref>], which detects fragmented DNA in situ in the cell nucleus. The assay was performed using the TUNEL Apoptosis Detection Kit (EMD Millipore, Temecula, CA), according to the manufacturer's instructions with some modifications. Cardiac sections prepared as above indicated, then incubated with 50&#x02009;<italic>&#x003bc;</italic>L of proteinase K for 30&#x02009;min in a humid chamber and washed with PBS. Then, sections were incubated with the TdT end-labeling cocktail that contains TdT and biotinylated dUTP, for 5&#x02009;min at room temperature. Each step was followed by PBS washes. Then, sections were incubated with blocking buffer for 20&#x02009;min at room temperature. After this, FITC-labeled avidin was applied for 30&#x02009;min at 37&#x000b0;C in a humid chamber. Sections were washed twice with PBS for 15&#x02009;min at room temperature in the dark and then counterstained with propidium iodide (1&#x02009;:&#x02009;2000) for 15&#x02009;min. Sections treated with DNAse I was used as positive controls. Sections in which treatment with proteinase K was replaced by PBS were used as negative control. After finishing the protocol, sections were observed with a Zeiss LSM-700 confocal microscope and TUNEL positive cells and total cells were counted. The apoptotic index represents the number of TUNEL<sup>+</sup> cells to total number of cells. This percentage was compared between groups.</p></sec><sec id="sec2.4"><title>2.4. Real-Time PCR</title><p>For quantitative polymerase chain reaction (qPCR), total RNA was extracted from rats hearts using TRIzol reagent and reversed transcribed using high capacity cDNA reverse transcription kit (Applied Biosystems, Foster City, CA). qPCR was performed in triplicate for each heart, using a 20&#x02009;<italic>&#x003bc;</italic>L mixture containing 1&#x02009;ng cDNA, TaqMan Master Mix, and TaqMan&#x000ae; Gene Expression Assays (Applied Biosystems) for NOX2 (Rn00576710_m1) and NOX4 (Rn00585380_m1). As an internal control, glyceraldehyde 3-phosphate dehydrogenase GAPDH (Rn01775763_g1) was determined in each reaction. Reaction conditions were set according to the manufacturer: one cycle of 50&#x000b0; for 2&#x02009;min, one cycle of 90&#x000b0; for 10&#x02009;min, and 40 cycles of 15&#x02009;s at 95&#x000b0; and 60&#x000b0; for 1&#x02009;min using an Mx3000P qPCR system (Agilent Technologies, CA, USA). Relative fold change was calculated by the 2<sup>&#x00394;Ct</sup> method and compared with baseline values as previously described [<xref rid="B28" ref-type="bibr">28</xref>].</p></sec><sec id="sec2.5"><title>2.5. Biopterin Measurements</title><p>Tetrahydrobiopterin (BH<sub>4</sub>) and dihydrobiopterin (BH<sub>2</sub>) were measured form cardiac homogenates, following the procedure described by Fukushima and Nixon [<xref rid="B29" ref-type="bibr">29</xref>], with modifications, by HPLC (Perkin Elmer series 200) separation and fluorescence detection at 350&#x02009;nm (Shimadzu RF-20A). The procedure involves a differential oxidation BH<sub>4</sub> and BH<sub>2</sub> with iodine in acidic and basic conditions. In acidic conditions, both BH<sub>4</sub> and BH<sub>2</sub> are oxidized to biopterins, while under basic conditions, only BH<sub>2</sub> is oxidized to biopterin. The difference in the content of biopterin between both oxidations represents the amount of BH<sub>4</sub>. Intracardiac BH<sub>4</sub> content was normalized to the total protein content of the sample.</p></sec><sec id="sec2.6"><title>2.6. Western Blotting</title><p>Cardiac tissue was homogenized in 3&#x02009;mL of lysis buffer (Tris 50&#x02009;mM, SDS 0.1%, NaCl 30&#x02009;mM, EDTA 2&#x02009;mM) supplemented with 30&#x02009;<italic>&#x003bc;</italic>L proteases inhibitors cocktail (MP Biomedicals, Solon, OH) using an ultraturrax, as previously described [<xref rid="B30" ref-type="bibr">30</xref>]. Then, the homogenate was centrifuged at 4000&#x02009;rpm for 10&#x02009;min at 4&#x000b0;C. The supernatant was removed and protein concentration was quantified using the BCA method (BCA Protein Assay Kit, Thermo Fisher Scientific, Rockford, IL). For this, 100&#x02009;<italic>&#x003bc;</italic>g of protein were mixed with Laemmli buffer, separated by SDS-PAGE, and blotted onto nitrocellulose membranes (Bio-Rad Laboratories, Hercules, CA). Antibodies used were the following: for NOX2 (anti-gp91<sup>phox</sup> 1&#x02009;:&#x02009;1000, catalog number: 611415, Lot: 15660), p67<sup>phox</sup> (1&#x02009;:&#x02009;1000, catalog number: 610913, Lot: 000079141) and eNOS (1&#x02009;:&#x02009;2000, catalog number: 610297, Lot: 35170) from BD Biosciences (San Jose, CA); for NOX4, from Thermo Scientific (1&#x02009;:&#x02009;1000, catalog number: PA1-46014), serine 16 phosphorylated phospholamban (1&#x02009;:&#x02009;1000, catalog number: A010-12, Lot: 0214-01) and total phospholamban (1&#x02009;:&#x02009;1000, catalog number: A101-14, Lot: 642016) were obtained from Badrilla (Leeds, UK); SERCA2 (1&#x02009;:&#x02009;2000, catalog number: SC 8094, Lot: C1115); GAPDH (1: 1000, catalog number: SC-365062, Lot: A2715); and secondary antibodies from Santa Cruz (Santa Cruz, CA). The protein bands were visualized using Supersignal West Femto Reagent (Pierce, Rockford, IL). Western blots were scanned and bands were quantified by densitometry analysis using ImageJ software.</p></sec><sec id="sec2.7"><title>2.7. Statistical Analysis</title><p>Results are expressed as mean&#x02009;&#x000b1;&#x02009;standard error. Comparisons between groups were performed using one-way analysis of variance (ANOVA) with Newman-Keuls and Dunnett as post hoc analysis, for data with normal distribution. For nonparametric data, Kruskal-Wallis test was applied, with Dunn's multiple comparisons test as post hoc analysis. Analysis of exercise training was performed using ANOVA with repeated measures. Statistical significance was set at a value of <italic>p</italic> &#x0003c; 0.05. These analyses were performed using the SPSS statistical package and the GraphPad Prism 5 software (San Diego, CA).</p></sec></sec><sec id="sec3"><title>3. Results</title><sec id="sec3.1"><title>3.1. Alloxan-Induced Diabetes in Rats</title><p>Alloxan injection induced hyperglycemia in rats as expected for a type 1 model of diabetes (<xref ref-type="table" rid="tab1">Table 1</xref>). Control animals increased body weight while both diabetic groups showed a slight weight reduction. All the animals in the training group completed the protocol and increased significantly their aerobic capacity (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Diabetic rats submitted to the exercise protocol showed reduced plasma glucose levels compared to the sedentary diabetic rats (<italic>p</italic> &#x0003c; 0.05).</p><p>Exercise training tests at baseline (before diabetes) for maximal velocity and maximal time were performed. These tests were repeated after the induction of diabetes (week 0) and with these values was estimated the 80% of maximal performance that were used the next week of training for each animal. In the subsequent weeks, this procedure was repeated. In this way, diabetic rats increased their exercise capacity significantly (see <xref ref-type="fig" rid="fig1">Figure 1()</xref>), specially the maximal velocity that increased each week, although they did not reach the baseline values (before diabetes). Nevertheless, at the end of the third and fourth week of training, the test maximal capacity (velocity and time) tests were not performed.</p></sec><sec id="sec3.2"><title>3.2. Cardiac Morphology</title><p>As it has been previously described, as part of the remodeling process that takes place in the diabetic heart, diabetes induced cellular hypertrophy of cardiomyocytes (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Compared to the hearts from control normoglycemic rats, diabetic rat hearts presented increased perimeter of cardiomyocytes: 73&#x02009;&#x000b1;&#x02009;7&#x02009;<italic>&#x003bc;</italic>m in the control group and 89.5&#x02009;&#x000b1;&#x02009;4.3&#x02009;<italic>&#x003bc;</italic>m in the diabetic group (<italic>p</italic> &#x0003c; 0.05), and this value was reduced in diabetic rats that underwent exercise: 78.7&#x02009;&#x000b1;&#x02009;2&#x02009;<italic>&#x003bc;</italic>m. Consistent with this, myocyte area was increased in diabetic hearts compared to that in controls and reduced in animals that underwent physical training: 297&#x02009;&#x000b1;&#x02009;17&#x02009;<italic>&#x003bc;</italic>m<sup>2</sup> in control rats, 446&#x02009;&#x000b1;&#x02009;26&#x02009;m<sup>2</sup> in diabetic rats, and 363&#x02009;&#x000b1;&#x02009;14&#x02009;<italic>&#x003bc;</italic>m<sup>2</sup> in the diabetic&#x02009;+&#x02009;exercise group (<italic>p</italic> &#x0003c; 0.05).</p><p>As expected, diabetes induced an increase in fibrosis as collagen deposition in the heart as part of the cardiac damage (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Nevertheless, chronic exercise reduced cardiac fibrosis: 4.43&#x02009;&#x000b1;&#x02009;0.9% of fibrosis in the control group, 8.68&#x02009;&#x000b1;&#x02009;0.7% in diabetic rats, and 5.72&#x02009;&#x000b1;&#x02009;0.7% diabetic hearts from the rats that underwent high-intensity exercise.</p></sec><sec id="sec3.3"><title>3.3. Apoptosis</title><p>It has been observed that diabetes is associated with increased degree of apoptosis in the myocardium [<xref rid="B31" ref-type="bibr">31</xref>]. For this reason, we investigated this type of cell death in our experimental animals, using the TUNEL assay (<xref ref-type="fig" rid="fig4">Figure 4</xref>). In the control normoglycemic and diabetic rats, the level of apoptotic index was low: 1.9&#x02009;&#x000b1;&#x02009;2.2 and 1.5&#x02009;&#x000b1;&#x02009;2%, respectively. Unexpectedly, this level was increased substantially in the diabetic&#x02009;+&#x02009;exercise group: 6.5&#x02009;&#x000b1;&#x02009;10.2% (<italic>p</italic> &#x0003c; 0.05). These data suggest that high-intensity exercise training induced an increase in cardiomyocytes apoptotic death.</p></sec><sec id="sec3.4"><title>3.4. NADPH Oxidases</title><p>Diabetes is associated with an increase in oxidative stress in the myocardium, particularly derived from NADPH oxidases as source of reactive oxygen species [<xref rid="B32" ref-type="bibr">32</xref>]. For this reason, we first looked into the expression at the level of NOX2 and NOX4 mRNA (<xref ref-type="fig" rid="fig5">Figure 5</xref>), the two main isoforms of NADPH oxidases that are expressed in the heart and, specifically, in the cardiac myocyte. Diabetes induced a twofold increase in the NOX2 mRNA level, compared to control normoglycemic animals (<italic>p</italic> &#x0003c; 0.05). Unexpectedly, exercise increased this level about eightfold. In the case of NOX4, diabetes also increased the mRNA levels (<italic>p</italic> &#x0003c; 0.05), and in the diabetes&#x02009;+&#x02009;exercise group, this increase was even more pronounced, although with substantial variability.</p><p>Next, we tested whether this increase in the NOX mRNA levels was followed by increased protein expression. For this purpose, we performed SDS-PAGE and Western blotting assays of cardiac samples (<xref ref-type="fig" rid="fig6">Figure 6</xref>). In the case of the protein levels of NOX2, both the diabetes and diabetes&#x02009;+&#x02009;exercise groups showed about a sevenfold increase. In the case of NOX4, there was a trend of increase but not statistically significant. On the contrary, the levels of p67<sup>phox</sup>, one of the regulatory subunits of NOX2, also showed a significant increase in the diabetic&#x02009;+&#x02009;exercise group (<italic>p</italic> &#x0003c; 0.05). These data suggest that the components of NOX2 are upregulated, increasing the levels of myocardial oxidative stress, especially in the group submitted to high-intensity exercise training.</p></sec><sec id="sec3.5"><title>3.5. Nitric Oxide Synthase</title><p>Next, we examined the nitric oxide pathway, which has been shown to be cardioprotective. First, we evaluated the cardiac levels of the endothelial nitric oxide synthase, by Western blotting (<xref ref-type="fig" rid="fig7">Figure 7</xref>). Neither diabetes nor exercise induced changes in the levels of eNOS (<italic>p</italic> = 0.4139).</p><p>A direct consequence of the increased production of reactive oxygen species (ROS) is the uncoupling of nitric oxide synthase. The oxidation of BH<sub>4</sub>, an essential cofactor for NOS activity, leads to the dissociation of NOS as a dimer into monomers. We quantified the levels of eNOS as a dimer and a monomer by Western blot under nonreducing conditions (<xref ref-type="fig" rid="fig7">Figure 7</xref>). This analysis revealed that diabetes induced strong eNOS uncoupling, increasing the formation of its monomer. High-intensity exercise was unable to restore eNOS as dimer. The eNOS dimer/monomer ratio was 1.3&#x02009;&#x000b1;&#x02009;0.4 in the control group, 0.38&#x02009;&#x000b1;&#x02009;0.04 in the diabetic group, and 0.26&#x02009;&#x000b1;&#x02009;0.03 in the diabetic&#x02009;+&#x02009;exercise group (<italic>p</italic> &#x0003c; 0.05). Furthermore, exercise was unable to restore the intracardiac levels of BH<sub>4</sub>, an essential cofactor for NOS activity, that were reduced in diabetic rats: 111.1&#x02009;&#x000b1;&#x02009;49.2&#x02009;pmol/g protein in the control group, 17.9&#x02009;&#x000b1;&#x02009;2.6 in the diabetic group, and 17.4&#x02009;&#x000b1;&#x02009;3.7 in the diabetic + exercise group (<italic>p</italic> &#x0003c; 0.05). This result explains that both diabetic groups showed increased eNOS as monomer, in the uncoupled state. In most samples, BH<sub>2</sub> levels were undetectable, for this reason, results are expressed as BH<sub>4</sub> normalized to protein concentration, instead of a ratio BH<sub>4</sub>/BH<sub>2</sub>.</p></sec><sec id="sec3.6"><title>3.6. Calcium Handling Proteins</title><p>Finally, we evaluated the level of Ca<sup>2+</sup> handling proteins, to gain information regarding the status of the excitation contraction coupling elements in the diabetic hearts. Phospholamban (PLB) is a negative regulator of the sarcoplasmic calcium pump SERCA2 [<xref rid="B33" ref-type="bibr">33</xref>]. When PLB phosphorylated at serine 16 (by protein kinase A), it unleashes SERCA2 from its inhibition, being able to increase the Ca<sup>2+</sup> reuptake to the sarcoplasmic reticulum. While the total levels of PLB were not altered by diabetes (<xref ref-type="fig" rid="fig8">Figure 8</xref>), the degree of PLB phosphorylation at serine 16 was reduced in diabetic animals and was not recovered by exercise (<italic>p</italic> &#x0003c; 0.05), suggesting impaired intracellular Ca<sup>2+</sup> handling. We also assessed the levels of SERCA2. Both diabetic groups presented decreased levels of SERCA2 compared to nondiabetic rats (<italic>p</italic> &#x0003c; 0.05), which is associated with cardiac dysfunction, as the capacity to store Ca<sup>2+</sup> in the sarcoplasmic reticulum is reduced (systolic function), and the velocity of relaxation is reduced (diastolic function).</p></sec></sec><sec id="sec4"><title>4. Discussion</title><p>Exercise appears as an effective strategy for diabetic patients and has been recommended in moderate and high intensity [<xref rid="B15" ref-type="bibr">15</xref>]. In this study, we evaluated the effects of a high-intensity physical exercise training protocol on cardiac remodeling and myocardial proteins involved in the nitroso-redox balance in an animal model of type 1 diabetes. We found that this training program had a positive impact on cardiac remodeling, evidenced as reduction in myocyte hypertrophy and reduced collagen deposition (fibrosis), but was unable to restore the nitroso-redox environment. NADPH oxidase 2 system (NOX2) was upregulated; there were no changes in eNOS levels, but the degree of eNOS uncoupling was increased, being a potential additional source of superoxide. Furthermore, this probably increase in oxidative stress was associated with increased degree of cardiac apoptosis in diabetic animals submitted to the exercise program and reduced phospholamban phosphorylation. These data also suggest that the reverse remodeling process may be independent of increased oxidative stress. For example, it has been suggested that moderate-intensity training decreases myocyte cross-sectional area [<xref rid="B24" ref-type="bibr">24</xref>]. Interestingly, the high-intensity training increased the degree of apoptosis. This is contrary to what has been observed in rats under low-intensity exercise [<xref rid="B18" ref-type="bibr">18</xref>], which reduced the apoptotic index associated with a recovery in the level of antioxidant enzymes glutathione peroxidase, catalase, and superoxide dismutase. Nevertheless, in that study, plasma levels of glucose reached about 300&#x02009;mg/dL in the diabetic animals, much lower compared to those in our study (around 600&#x02009;mg/dL in the diabetic rats). In another recent study, Gimenes et al. in a similar low-intensity exercise protocol also observed a recovery in the cardiac levels of catalase and glutathione peroxidase, with glucose plasma levels around 500&#x02009;mg/dL (similar to this study) [<xref rid="B34" ref-type="bibr">34</xref>].</p><p>Regarding the NADPH oxidase system, diabetes induced an increase in both NOX2 and NOX4 mRNA that was not reversed by exercise. Furthermore, NOX2 protein and p67<sup>phox</sup>, one of its regulatory subunits, were also increased in diabetes and not reversed by exercise, strongly suggesting an increased ROS production.</p><p>In a recent report, Sharma et al. described that in a protocol of exercise similar to ours, they observed a reduction in the levels of the mRNA (although not measured by quantitative PCR) and protein of p47<sup>phox</sup> and p67<sup>phox</sup>, the regulatory subunits of NOX2, in the left ventricle of diabetic rats submitted to exercise training [<xref rid="B35" ref-type="bibr">35</xref>]. But again, the plasma glucose levels in diabetic animals attained about 300&#x02009;mg/dL, which appears to be in important factor on the observed results.</p><p>It is possible that the reverse remodeling observed in the exercise-trained rats may be independent of oxidative stress but dependent, for example, on reverse of metabolic pathways such as nonoxidative glucose pathways [<xref rid="B26" ref-type="bibr">26</xref>]. In our study, exercise reduced the plasma levels of the advanced glycation end-products (AGEs, data not shown) in the diabetic animals. On the other hand, NOX-derived ROS may have induced signaling pathways converging, for instance, in increased autophagy [<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B37" ref-type="bibr">37</xref>]. Autophagy is a homeostatic process important during stress conditions, aimed to obtain energy and amino acids from the degradation of proteins and organelles [<xref rid="B38" ref-type="bibr">38</xref>]. ROS produced by NOX2 and 4 may increase the process of autophagy in the diabetic heart. This increased autophagic flux may be beneficial for the diabetic heart [<xref rid="B39" ref-type="bibr">39</xref>].</p><p>Interestingly, our study showed an increase in the degree of uncoupling of the enzyme, associated with a reduction of the NOS cofactor BH<sub>4</sub>. It is possible that the increased oxidative stress derived from NOX2 and other sources may have been responsible for the reduced levels of BH<sub>4</sub>, since this molecule has been shown to be redox sensitive [<xref rid="B40" ref-type="bibr">40</xref>, <xref rid="B41" ref-type="bibr">41</xref>].</p><p>Strategies to recover cardiac BH<sub>4</sub> in diabetic animals have shown promising results reducing remodeling and improving ventricular function [<xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B13" ref-type="bibr">13</xref>]. Farah et al. showed that a high-intensity exercise increased the degree of eNOS dimerization [<xref rid="B42" ref-type="bibr">42</xref>]. Nevertheless, this increase was lost upon ischemia and even reduced upon reperfusion. This reinforces the concept that eNOS uncoupling is induced by oxidative environments, as those observed in cardiovascular diseases and diabetes [<xref rid="B43" ref-type="bibr">43</xref>&#x02013;<xref rid="B45" ref-type="bibr">45</xref>].</p><p>In addition, it has been shown that NOS activity is related to phospholamban phosphorylation [<xref rid="B46" ref-type="bibr">46</xref>], a key protein in the regulation of the excitation-contraction coupling, as a regulator of SERCA2. On the other hand, it has been reported that diabetes reduces phospholamban phosphorylation [<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B46" ref-type="bibr">46</xref>], in agreement with our observations. Exercise was unable to restore this phosphorylation, probably reducing the capacity of the sarcoplasmic reticulum for Ca<sup>2+</sup> reuptake, along with the reduced levels of SERCA2. Nevertheless, in the diabetic heart, other abnormalities in the excitation-contraction coupling machinery are also present, like the ryanodine receptor and the Na/Ca exchanger [<xref rid="B47" ref-type="bibr">47</xref>&#x02013;<xref rid="B49" ref-type="bibr">49</xref>].</p><p>Another possibility is that exercise training may have reduced inflammatory mediators in the diabetic myocardium. da Silva et al. found in rats treated with streptozotocin that a low-intensity swimming training reduced intramyocardial levels of TNF-alpha associated with a reverse remodeling of the diabetic hearts [<xref rid="B50" ref-type="bibr">50</xref>].</p></sec><sec id="sec5"><title>5. Conclusions</title><p>In conclusion, the present results suggest that high-intensity exercise is able to reverse cardiac remodeling in the diabetic heart but is unable to restore the nitroso-redox imbalance imposed and observed in this condition. This later could by restored by pharmacological manipulations that may include antioxidants and tetrahydrobiopterin.</p></sec></body><back><ack><title>Acknowledgments</title><p>This study was funded by grant Fondo Nacional de Desarrollo Cient&#x000ed;fico y Tecnol&#x000f3;gico 1150662 (Daniel R. Gonzalez) and the Program of Excellence Interdisciplinary Research QuimBio Universidad de Talca. The authors thank Karla Valdes for the technical assistance and Adriana V. Treuer for helping with the confocal microscopy and figures edition.</p></ack><sec><title>Conflicts of Interest</title><p>The authors declare that they have no conflicts of interest.</p></sec><ref-list><ref id="B1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zimmet</surname><given-names>P.</given-names></name><name><surname>Alberti</surname><given-names>K. G.</given-names></name><name><surname>Shaw</surname><given-names>J.</given-names></name></person-group><article-title>Global and societal implications of the diabetes epidemic</article-title><source><italic>Nature</italic></source><year>2001</year><volume>414</volume><issue>6865</issue><fpage>782</fpage><lpage>787</lpage><pub-id pub-id-type="doi">10.1038/414782a</pub-id><pub-id pub-id-type="other">2-s2.0-0035856920</pub-id><pub-id pub-id-type="other">0035856920</pub-id><?supplied-pmid 11742409?><pub-id pub-id-type="pmid">11742409</pub-id></element-citation></ref><ref id="B2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>J. E.</given-names></name><name><surname>Sicree</surname><given-names>R. A.</given-names></name><name><surname>Zimmet</surname><given-names>P. Z.</given-names></name></person-group><article-title>Global estimates of the prevalence of diabetes for 2010 and 2030</article-title><source><italic>Diabetes Research and Clinical Practice</italic></source><year>2010</year><volume>87</volume><issue>1</issue><fpage>4</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/j.diabres.2009.10.007</pub-id><pub-id pub-id-type="other">2-s2.0-73749083481</pub-id><pub-id pub-id-type="other">73749083481</pub-id><?supplied-pmid 19896746?><pub-id pub-id-type="pmid">19896746</pub-id></element-citation></ref><ref id="B3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asghar</surname><given-names>O.</given-names></name><name><surname>Al-Sunni</surname><given-names>A.</given-names></name><name><surname>Khavandi</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Diabetic cardiomyopathy</article-title><source><italic>Clinical Science (London, England)</italic></source><year>2009</year><volume>116</volume><issue>10</issue><fpage>741</fpage><lpage>760</lpage><pub-id pub-id-type="doi">10.1042/CS20080500</pub-id><pub-id pub-id-type="other">2-s2.0-67649285971</pub-id></element-citation></ref><ref id="B4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huynh</surname><given-names>K.</given-names></name><name><surname>Bernardo</surname><given-names>B. C.</given-names></name><name><surname>McMullen</surname><given-names>J. R.</given-names></name><name><surname>Ritchie</surname><given-names>R. H.</given-names></name></person-group><article-title>Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways</article-title><source><italic>Pharmacology &#x00026; Therapeutics</italic></source><year>2014</year><volume>142</volume><issue>3</issue><fpage>375</fpage><lpage>415</lpage><pub-id pub-id-type="doi">10.1016/j.pharmthera.2014.01.003</pub-id><pub-id pub-id-type="other">2-s2.0-84898920521</pub-id><pub-id pub-id-type="other">84898920521</pub-id><?supplied-pmid 24462787?><pub-id pub-id-type="pmid">24462787</pub-id></element-citation></ref><ref id="B5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falcao-Pires</surname><given-names>I.</given-names></name><name><surname>Leite-Moreira</surname><given-names>A. F.</given-names></name></person-group><article-title>Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment</article-title><source><italic>Heart Failure Reviews</italic></source><year>2012</year><volume>17</volume><issue>3</issue><fpage>325</fpage><lpage>344</lpage><pub-id pub-id-type="doi">10.1007/s10741-011-9257-z</pub-id><pub-id pub-id-type="other">2-s2.0-84862568080</pub-id><pub-id pub-id-type="other">84862568080</pub-id><?supplied-pmid 21626163?><pub-id pub-id-type="pmid">21626163</pub-id></element-citation></ref><ref id="B6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordano</surname><given-names>F. J.</given-names></name></person-group><article-title>Oxygen, oxidative stress, hypoxia, and heart failure</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2005</year><volume>115</volume><issue>3</issue><fpage>500</fpage><lpage>508</lpage><pub-id pub-id-type="doi">10.1172/JCI24408</pub-id><pub-id pub-id-type="other">14644442283</pub-id><?supplied-pmid 15765131?><pub-id pub-id-type="pmid">15765131</pub-id></element-citation></ref><ref id="B7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lorenzo</surname><given-names>O.</given-names></name><name><surname>Ramirez</surname><given-names>E.</given-names></name><name><surname>Picatoste</surname><given-names>B.</given-names></name><name><surname>Egido</surname><given-names>J.</given-names></name><name><surname>Tu&#x000f1;&#x000f3;n</surname><given-names>J.</given-names></name></person-group><article-title>Alteration of energy substrates and ROS production in diabetic cardiomyopathy</article-title><source><italic>Mediators of Inflammation</italic></source><year>2013</year><volume>2013</volume><fpage>11</fpage><pub-id pub-id-type="publisher-id">461967</pub-id><pub-id pub-id-type="doi">10.1155/2013/461967</pub-id><pub-id pub-id-type="other">2-s2.0-84888027415</pub-id><?supplied-pmid 24288443?><pub-id pub-id-type="pmid">24288443</pub-id></element-citation></ref><ref id="B8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ansley</surname><given-names>D. M.</given-names></name><name><surname>Wang</surname><given-names>B.</given-names></name></person-group><article-title>Oxidative stress and myocardial injury in the diabetic heart</article-title><source><italic>The Journal of Pathology</italic></source><year>2013</year><volume>229</volume><issue>2</issue><fpage>232</fpage><lpage>241</lpage><pub-id pub-id-type="doi">10.1002/path.4113</pub-id><pub-id pub-id-type="other">2-s2.0-84871092804</pub-id><pub-id pub-id-type="other">84871092804</pub-id><?supplied-pmid 23011912?><pub-id pub-id-type="pmid">23011912</pub-id></element-citation></ref><ref id="B9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rajesh</surname><given-names>M.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>P.</given-names></name><name><surname>Batkai</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Xanthine oxidase inhibitor allopurinol attenuates the development of diabetic cardiomyopathy</article-title><source><italic>Journal of Cellular and Molecular Medicine</italic></source><year>2009</year><volume>13</volume><issue>8B</issue><fpage>2330</fpage><lpage>2341</lpage><pub-id pub-id-type="doi">10.1111/j.1582-4934.2008.00564.x</pub-id><pub-id pub-id-type="other">2-s2.0-72949089507</pub-id><?supplied-pmid 19175688?><pub-id pub-id-type="pmid">19175688</pub-id></element-citation></ref><ref id="B10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maalouf</surname><given-names>R. M.</given-names></name><name><surname>Eid</surname><given-names>A. A.</given-names></name><name><surname>Gorin</surname><given-names>Y. C.</given-names></name><etal/></person-group><article-title>Nox4-derived reactive oxygen species mediate cardiomyocyte injury in early type 1 diabetes</article-title><source><italic>American Journal of Physiology. Cell Physiology</italic></source><year>2012</year><volume>302</volume><issue>3</issue><fpage>C597</fpage><lpage>C604</lpage><pub-id pub-id-type="doi">10.1152/ajpcell.00331.2011</pub-id><pub-id pub-id-type="other">2-s2.0-84856248012</pub-id><?supplied-pmid 22031600?><pub-id pub-id-type="pmid">22031600</pub-id></element-citation></ref><ref id="B11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumgardt</surname><given-names>S. L.</given-names></name><name><surname>Paterson</surname><given-names>M.</given-names></name><name><surname>Leucker</surname><given-names>T. M.</given-names></name><etal/></person-group><article-title>Chronic co-administration of sepiapterin and l-citrulline ameliorates diabetic cardiomyopathy and myocardial ischemia/reperfusion injury in obese type 2 diabetic mice</article-title><source><italic>Circulation. Heart Failure</italic></source><year>2016</year><volume>9</volume><issue>1, article e002424</issue><pub-id pub-id-type="doi">10.1161/CIRCHEARTFAILURE.115.002424</pub-id><pub-id pub-id-type="other">2-s2.0-84955258675</pub-id><?supplied-pmid 26763290?><pub-id pub-id-type="pmid">26763290</pub-id></element-citation></ref><ref id="B12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roe</surname><given-names>N. D.</given-names></name><name><surname>He</surname><given-names>E. Y.</given-names></name><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Ren</surname><given-names>J.</given-names></name></person-group><article-title>Folic acid reverses nitric oxide synthase uncoupling and prevents cardiac dysfunction in insulin resistance: role of Ca<sup>2+</sup>/calmodulin-activated protein kinase II</article-title><source><italic>Free Radical Biology and Medicine</italic></source><year>2013</year><volume>65</volume><fpage>234</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2013.06.042</pub-id><pub-id pub-id-type="other">2-s2.0-84884559944</pub-id><pub-id pub-id-type="other">84884559944</pub-id><?supplied-pmid 23820268?><pub-id pub-id-type="pmid">23820268</pub-id></element-citation></ref><ref id="B13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jo</surname><given-names>H.</given-names></name><name><surname>Otani</surname><given-names>H.</given-names></name><name><surname>Jo</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice</article-title><source><italic>Clinical and Experimental Pharmacology &#x00026; Physiology</italic></source><year>2011</year><volume>38</volume><issue>8</issue><fpage>485</fpage><lpage>493</lpage><pub-id pub-id-type="doi">10.1111/j.1440-1681.2011.05535.x</pub-id><pub-id pub-id-type="other">2-s2.0-79960711345</pub-id><pub-id pub-id-type="other">79960711345</pub-id><?supplied-pmid 21554376?><pub-id pub-id-type="pmid">21554376</pub-id></element-citation></ref><ref id="B14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gielen</surname><given-names>S.</given-names></name><name><surname>Laughlin</surname><given-names>M. H.</given-names></name><name><surname>O'Conner</surname><given-names>C.</given-names></name><name><surname>Duncker</surname><given-names>D. J.</given-names></name></person-group><article-title>Exercise training in patients with heart disease: review of beneficial effects and clinical recommendations</article-title><source><italic>Progress in Cardiovascular Diseases</italic></source><year>2015</year><volume>57</volume><issue>4</issue><fpage>347</fpage><lpage>355</lpage><pub-id pub-id-type="doi">10.1016/j.pcad.2014.10.001</pub-id><pub-id pub-id-type="other">2-s2.0-84920167367</pub-id><pub-id pub-id-type="other">84920167367</pub-id><?supplied-pmid 25459973?><pub-id pub-id-type="pmid">25459973</pub-id></element-citation></ref><ref id="B15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marwick</surname><given-names>T. H.</given-names></name><name><surname>Hordern</surname><given-names>M. D.</given-names></name><name><surname>Miller</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association</article-title><source><italic>Circulation</italic></source><year>2009</year><volume>119</volume><issue>25</issue><fpage>3244</fpage><lpage>3262</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.109.192521</pub-id><pub-id pub-id-type="other">2-s2.0-67650740049</pub-id><pub-id pub-id-type="other">67650740049</pub-id><?supplied-pmid 19506108?><pub-id pub-id-type="pmid">19506108</pub-id></element-citation></ref><ref id="B16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tikkanen-Dolenc</surname><given-names>H.</given-names></name><name><surname>Waden</surname><given-names>J.</given-names></name><name><surname>Forsblom</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Frequent and intensive physical activity reduces risk of cardiovascular events in type 1 diabetes</article-title><source><italic>Diabetologia</italic></source><year>2017</year><volume>60</volume><issue>3</issue><fpage>574</fpage><lpage>580</lpage><pub-id pub-id-type="doi">10.1007/s00125-016-4189-8</pub-id><pub-id pub-id-type="other">2-s2.0-85007154339</pub-id><pub-id pub-id-type="other">85007154339</pub-id><?supplied-pmid 28013340?><pub-id pub-id-type="pmid">28013340</pub-id></element-citation></ref><ref id="B17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Broderick</surname><given-names>T. L.</given-names></name><name><surname>Poirier</surname><given-names>P.</given-names></name><name><surname>Gillis</surname><given-names>M.</given-names></name></person-group><article-title>Exercise training restores abnormal myocardial glucose utilization and cardiac function in diabetes</article-title><source><italic>Diabetes/Metabolism Research and Reviews</italic></source><year>2005</year><volume>21</volume><issue>1</issue><fpage>44</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1002/dmrr.479</pub-id><pub-id pub-id-type="other">2-s2.0-12744280913</pub-id><pub-id pub-id-type="other">12744280913</pub-id><?supplied-pmid 15386820?><pub-id pub-id-type="pmid">15386820</pub-id></element-citation></ref><ref id="B18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanter</surname><given-names>M.</given-names></name><name><surname>Aksu</surname><given-names>F.</given-names></name><name><surname>Takir</surname><given-names>M.</given-names></name><name><surname>Kostek</surname><given-names>O.</given-names></name><name><surname>Kanter</surname><given-names>B.</given-names></name><name><surname>Oymagil</surname><given-names>A.</given-names></name></person-group><article-title>Effects of low intensity exercise against apoptosis and oxidative stress in Streptozotocin-induced diabetic rat heart</article-title><source><italic>Experimental and Clinical Endocrinology &#x00026; Diabetes</italic></source><year>2016</year><pub-id pub-id-type="doi">10.1055/s-0035-1569332</pub-id><pub-id pub-id-type="other">2-s2.0-84959295285</pub-id><?supplied-pmid 26824288?><pub-id pub-id-type="pmid">26824288</pub-id></element-citation></ref><ref id="B19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Loganathan</surname><given-names>R.</given-names></name><name><surname>Bilgen</surname><given-names>M.</given-names></name><name><surname>Al-Hafez</surname><given-names>B.</given-names></name><name><surname>Zhero</surname><given-names>S. V.</given-names></name><name><surname>Alenezy</surname><given-names>M. D.</given-names></name><name><surname>Smirnova</surname><given-names>I. V.</given-names></name></person-group><article-title>Exercise training improves cardiac performance in diabetes: in vivo demonstration with quantitative cine-MRI analyses</article-title><source><italic>Journal of Applied Physiology (1985 )</italic></source><year>2007</year><volume>102</volume><issue>2</issue><fpage>665</fpage><lpage>672</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00521.2006</pub-id><pub-id pub-id-type="other">2-s2.0-33846889747</pub-id><?supplied-pmid 17082374?><pub-id pub-id-type="pmid">17082374</pub-id></element-citation></ref><ref id="B20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>S.</given-names></name><name><surname>Thoma</surname><given-names>C.</given-names></name><name><surname>Houghton</surname><given-names>D.</given-names></name><name><surname>Trenell</surname><given-names>M. I.</given-names></name></person-group><article-title>High-intensity interval training: a review of its impact on glucose control and cardiometabolic health</article-title><source><italic>Diabetologia</italic></source><year>2017</year><volume>60</volume><issue>1</issue><fpage>7</fpage><lpage>23</lpage><pub-id pub-id-type="doi">10.1007/s00125-016-4106-1</pub-id><pub-id pub-id-type="other">84988986008</pub-id><?supplied-pmid 27681241?><pub-id pub-id-type="pmid">27681241</pub-id></element-citation></ref><ref id="B21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jonker</surname><given-names>J. T.</given-names></name><name><surname>de Mol</surname><given-names>P.</given-names></name><name><surname>de Vries</surname><given-names>S. T.</given-names></name><etal/></person-group><article-title>Exercise and type 2 diabetes mellitus: changes in tissue-specific fat distribution and cardiac function</article-title><source><italic>Radiology</italic></source><year>2013</year><volume>269</volume><issue>2</issue><fpage>434</fpage><lpage>442</lpage><pub-id pub-id-type="doi">10.1148/radiol.13121631</pub-id><pub-id pub-id-type="other">2-s2.0-84886648703</pub-id><pub-id pub-id-type="other">84886648703</pub-id><?supplied-pmid 23801768?><pub-id pub-id-type="pmid">23801768</pub-id></element-citation></ref><ref id="B22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cassidy</surname><given-names>S.</given-names></name><name><surname>Thoma</surname><given-names>C.</given-names></name><name><surname>Hallsworth</surname><given-names>K.</given-names></name><etal/></person-group><article-title>High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial</article-title><source><italic>Diabetologia</italic></source><year>2016</year><volume>59</volume><issue>1</issue><fpage>56</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.1007/s00125-015-3741-2</pub-id><pub-id pub-id-type="other">2-s2.0-84946500948</pub-id><?supplied-pmid 26350611?><pub-id pub-id-type="pmid">26350611</pub-id></element-citation></ref><ref id="B23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname><given-names>J. D.</given-names></name><name><surname>Fletcher</surname><given-names>J. P.</given-names></name><name><surname>Mathis</surname><given-names>R. A.</given-names></name><name><surname>Cade</surname><given-names>W. T.</given-names></name></person-group><article-title>Effects of moderate- versus high-intensity exercise training on physical fitness and physical function in people with type 2 diabetes: a randomized clinical trial</article-title><source><italic>Physical Therapy</italic></source><year>2014</year><volume>94</volume><issue>12</issue><fpage>1720</fpage><lpage>1730</lpage><pub-id pub-id-type="doi">10.2522/ptj.20140097</pub-id><pub-id pub-id-type="other">2-s2.0-84914163522</pub-id><pub-id pub-id-type="other">84914163522</pub-id><?supplied-pmid 25082918?><pub-id pub-id-type="pmid">25082918</pub-id></element-citation></ref><ref id="B24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sturgeon</surname><given-names>K.</given-names></name><name><surname>Muthukumaran</surname><given-names>G.</given-names></name><name><surname>Ding</surname><given-names>D.</given-names></name><name><surname>Bajulaiye</surname><given-names>A.</given-names></name><name><surname>Ferrari</surname><given-names>V.</given-names></name><name><surname>Libonati</surname><given-names>J. R.</given-names></name></person-group><article-title>Moderate-intensity treadmill exercise training decreases murine cardiomyocyte cross-sectional area</article-title><source><italic>Physiologival Reports</italic></source><year>2015</year><volume>3</volume><issue>5</issue><fpage>1</fpage><lpage>10</lpage><pub-id pub-id-type="doi">10.14814/phy2.12406</pub-id><pub-id pub-id-type="other">2-s2.0-84990841904</pub-id><pub-id pub-id-type="other">84990841904</pub-id><?supplied-pmid 25991723?><pub-id pub-id-type="pmid">25991723</pub-id></element-citation></ref><ref id="B25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ignarro</surname><given-names>L. J.</given-names></name><name><surname>Balestrieri</surname><given-names>M. L.</given-names></name><name><surname>Napoli</surname><given-names>C.</given-names></name></person-group><article-title>Nutrition, physical activity, and cardiovascular disease: an update</article-title><source><italic>Cardiovascular Research</italic></source><year>2007</year><volume>73</volume><issue>2</issue><fpage>326</fpage><lpage>340</lpage><pub-id pub-id-type="doi">10.1016/j.cardiores.2006.06.030</pub-id><pub-id pub-id-type="other">2-s2.0-33845652606</pub-id><pub-id pub-id-type="other">33845652606</pub-id><?supplied-pmid 16945357?><pub-id pub-id-type="pmid">16945357</pub-id></element-citation></ref><ref id="B26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hafstad</surname><given-names>A. D.</given-names></name><name><surname>Boardman</surname><given-names>N.</given-names></name><name><surname>Aasum</surname><given-names>E.</given-names></name></person-group><article-title>How exercise may amend metabolic disturbances in diabetic cardiomyopathy</article-title><source><italic>Antioxidants &#x00026; Redox Signaling</italic></source><year>2015</year><volume>22</volume><issue>17</issue><fpage>1587</fpage><lpage>1605</lpage><pub-id pub-id-type="doi">10.1089/ars.2015.6304</pub-id><pub-id pub-id-type="other">2-s2.0-84930686190</pub-id><pub-id pub-id-type="other">84930686190</pub-id><?supplied-pmid 25738326?><pub-id pub-id-type="pmid">25738326</pub-id></element-citation></ref><ref id="B27"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanashiro-Takeuchi</surname><given-names>R. M.</given-names></name><name><surname>Takeuchi</surname><given-names>L. M.</given-names></name><name><surname>Rick</surname><given-names>F. G.</given-names></name><etal/></person-group><article-title>Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI)</article-title><source><italic>Proceedings of the National Academy of Sciences of the United States of America</italic></source><year>2012</year><volume>109</volume><issue>2</issue><fpage>559</fpage><lpage>563</lpage><pub-id pub-id-type="doi">10.1073/pnas.1119203109</pub-id><pub-id pub-id-type="other">2-s2.0-84855998730</pub-id><?supplied-pmid 22203988?><pub-id pub-id-type="pmid">22203988</pub-id></element-citation></ref><ref id="B28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalez</surname><given-names>D. R.</given-names></name><name><surname>Treuer</surname><given-names>A. V.</given-names></name><name><surname>Lamirault</surname><given-names>G.</given-names></name><etal/></person-group><article-title>NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic cardiomyopathy</article-title><source><italic>American Journal of Physiology. Heart and Circulatory Physiology</italic></source><year>2014</year><volume>307</volume><issue>5</issue><fpage>H710</fpage><lpage>H721</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00890.2013</pub-id><pub-id pub-id-type="other">2-s2.0-84906909923</pub-id><?supplied-pmid 25015966?><pub-id pub-id-type="pmid">25015966</pub-id></element-citation></ref><ref id="B29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fukushima</surname><given-names>T.</given-names></name><name><surname>Nixon</surname><given-names>J. C.</given-names></name></person-group><article-title>Analysis of reduced forms of biopterin in biological tissues and fluids</article-title><source><italic>Analytical Biochemistry</italic></source><year>1980</year><volume>102</volume><issue>1</issue><fpage>176</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/0003-2697(80)90336-X</pub-id><pub-id pub-id-type="other">2-s2.0-0018868814</pub-id><pub-id pub-id-type="other">0018868814</pub-id><?supplied-pmid 7356152?><pub-id pub-id-type="pmid">7356152</pub-id></element-citation></ref><ref id="B30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cavieres</surname><given-names>V.</given-names></name><name><surname>Valdes</surname><given-names>K.</given-names></name><name><surname>Moreno</surname><given-names>B.</given-names></name><name><surname>Moore-Carrasco</surname><given-names>R.</given-names></name><name><surname>Gonzalez</surname><given-names>D. R.</given-names></name></person-group><article-title>Vascular hypercontractility and endothelial dysfunction before development of atherosclerosis in moderate dyslipidemia: role for nitric oxide and interleukin-6</article-title><source><italic>American Journal of Cardiovascular Disease</italic></source><year>2014</year><volume>4</volume><issue>3</issue><fpage>114</fpage><lpage>122</lpage><?supplied-pmid 25360389?><pub-id pub-id-type="pmid">25360389</pub-id></element-citation></ref><ref id="B31"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frustaci</surname><given-names>A.</given-names></name><name><surname>Kajstura</surname><given-names>J.</given-names></name><name><surname>Chimenti</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Myocardial cell death in human diabetes</article-title><source><italic>Circulation Research</italic></source><year>2000</year><volume>87</volume><issue>12</issue><fpage>1123</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1161/01.RES.87.12.1123</pub-id><pub-id pub-id-type="other">0034623856</pub-id><?supplied-pmid 11110769?><pub-id pub-id-type="pmid">11110769</pub-id></element-citation></ref><ref id="B32"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cave</surname><given-names>A. C.</given-names></name><name><surname>Brewer</surname><given-names>A. C.</given-names></name><name><surname>Narayanapanicker</surname><given-names>A.</given-names></name><etal/></person-group><article-title>NADPH oxidases in cardiovascular health and disease</article-title><source><italic>Antioxidants &#x00026; Redox Signaling</italic></source><year>2006</year><volume>8</volume><issue>5-6</issue><fpage>691</fpage><lpage>728</lpage><pub-id pub-id-type="doi">10.1089/ars.2006.8.691</pub-id><pub-id pub-id-type="other">2-s2.0-33745883797</pub-id><pub-id pub-id-type="other">33745883797</pub-id><?supplied-pmid 16771662?><pub-id pub-id-type="pmid">16771662</pub-id></element-citation></ref><ref id="B33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vasanji</surname><given-names>Z.</given-names></name><name><surname>Dhalla</surname><given-names>N. S.</given-names></name><name><surname>Netticadan</surname><given-names>T.</given-names></name></person-group><article-title>Increased inhibition of SERCA2 by phospholamban in the type I diabetic heart</article-title><source><italic>Molecular and Cellular Biochemistry</italic></source><year>2004</year><volume>261</volume><issue>1</issue><fpage>245</fpage><lpage>249</lpage><pub-id pub-id-type="doi">10.1023/B:MCBI.0000028762.97754.26</pub-id><pub-id pub-id-type="other">2-s2.0-3442896500</pub-id><?supplied-pmid 15362510?><pub-id pub-id-type="pmid">15362510</pub-id></element-citation></ref><ref id="B34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gimenes</surname><given-names>C.</given-names></name><name><surname>Gimenes</surname><given-names>R.</given-names></name><name><surname>Rosa</surname><given-names>C. M.</given-names></name><etal/></person-group><article-title>Low intensity physical exercise attenuates cardiac remodeling and myocardial oxidative stress and dysfunction in diabetic rats</article-title><source><italic>Journal of Diabetes Research</italic></source><year>2015</year><volume>2015</volume><fpage>10</fpage><pub-id pub-id-type="publisher-id">457848</pub-id><pub-id pub-id-type="doi">10.1155/2015/457848</pub-id><pub-id pub-id-type="other">2-s2.0-84929957170</pub-id><?supplied-pmid 26509175?><pub-id pub-id-type="pmid">26509175</pub-id></element-citation></ref><ref id="B35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharma</surname><given-names>N. M.</given-names></name><name><surname>Rabeler</surname><given-names>B.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Raichlin</surname><given-names>E.</given-names></name><name><surname>Patel</surname><given-names>K. P.</given-names></name></person-group><article-title>Exercise training attenuates upregulation of p47<sup>phox</sup> and p67<sup>phox</sup> in hearts of diabetic rats</article-title><source><italic>Oxidative Medicine and Cellular Longevity</italic></source><year>2016</year><volume>2016</volume><fpage>11</fpage><pub-id pub-id-type="publisher-id">5868913</pub-id><pub-id pub-id-type="doi">10.1155/2016/5868913</pub-id><pub-id pub-id-type="other">2-s2.0-84959257422</pub-id><?supplied-pmid 26989452?><pub-id pub-id-type="pmid">26989452</pub-id></element-citation></ref><ref id="B36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciarretta</surname><given-names>S.</given-names></name><name><surname>Zhai</surname><given-names>P.</given-names></name><name><surname>Shao</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Activation of NADPH oxidase 4 in the endoplasmic reticulum promotes cardiomyocyte autophagy and survival during energy stress through the protein kinase RNA-activated-like endoplasmic reticulum kinase/eukaryotic initiation factor 2alpha/activating transcription factor 4 pathway</article-title><source><italic>Circulation Research</italic></source><year>2013</year><volume>113</volume><issue>11</issue><fpage>1253</fpage><lpage>1264</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.113.301787</pub-id><pub-id pub-id-type="other">2-s2.0-84888136345</pub-id><?supplied-pmid 24081881?><pub-id pub-id-type="pmid">24081881</pub-id></element-citation></ref><ref id="B37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sciarretta</surname><given-names>S.</given-names></name><name><surname>Volpe</surname><given-names>M.</given-names></name><name><surname>Sadoshima</surname><given-names>J.</given-names></name></person-group><article-title>NOX4 regulates autophagy during energy deprivation</article-title><source><italic>Autophagy</italic></source><year>2014</year><volume>10</volume><issue>4</issue><fpage>699</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.4161/auto.27955</pub-id><pub-id pub-id-type="other">2-s2.0-84898622190</pub-id><pub-id pub-id-type="other">84898622190</pub-id><?supplied-pmid 24492492?><pub-id pub-id-type="pmid">24492492</pub-id></element-citation></ref><ref id="B38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Varga</surname><given-names>Z. V.</given-names></name><name><surname>Giricz</surname><given-names>Z.</given-names></name><name><surname>Liaudet</surname><given-names>L.</given-names></name><name><surname>Hasko</surname><given-names>G.</given-names></name><name><surname>Ferdinandy</surname><given-names>P.</given-names></name><name><surname>Pacher</surname><given-names>P.</given-names></name></person-group><article-title>Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy</article-title><source><italic>Biochimica et Biophysica Acta</italic></source><year>2015</year><volume>1852</volume><issue>2</issue><fpage>232</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2014.06.030</pub-id><pub-id pub-id-type="other">2-s2.0-84919788547</pub-id><?supplied-pmid 24997452?><pub-id pub-id-type="pmid">24997452</pub-id></element-citation></ref><ref id="B39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Yang</surname><given-names>Q.</given-names></name><name><surname>Sun</surname><given-names>Y. Y.</given-names></name><etal/></person-group><article-title>Resveratrol-enhanced autophagic flux ameliorates myocardial oxidative stress injury in diabetic mice</article-title><source><italic>Journal of Cellular and Molecular Medicine</italic></source><year>2014</year><volume>18</volume><issue>8</issue><fpage>1599</fpage><lpage>1611</lpage><pub-id pub-id-type="doi">10.1111/jcmm.12312</pub-id><pub-id pub-id-type="other">2-s2.0-84912558699</pub-id><pub-id pub-id-type="other">84912558699</pub-id><?supplied-pmid 24889822?><pub-id pub-id-type="pmid">24889822</pub-id></element-citation></ref><ref id="B40"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crabtree</surname><given-names>M. J.</given-names></name><name><surname>Smith</surname><given-names>C. L.</given-names></name><name><surname>Lam</surname><given-names>G.</given-names></name><name><surname>Goligorsky</surname><given-names>M. S.</given-names></name><name><surname>Gross</surname><given-names>S. S.</given-names></name></person-group><article-title>Ratio of 5,6,7,8-tetrahydrobiopterin to 7,8-dihydrobiopterin in endothelial cells determines glucose-elicited changes in NO vs. superoxide production by eNOS</article-title><source><italic>American Journal of Physiology. Heart and Circulatory Physiology</italic></source><year>2008</year><volume>294</volume><issue>4</issue><fpage>H1530</fpage><lpage>H1540</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.00823.2007</pub-id><pub-id pub-id-type="other">2-s2.0-41849144894</pub-id><?supplied-pmid 18192221?><pub-id pub-id-type="pmid">18192221</pub-id></element-citation></ref><ref id="B41"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Landmesser</surname><given-names>U.</given-names></name><name><surname>Dikalov</surname><given-names>S.</given-names></name><name><surname>Price</surname><given-names>S. R.</given-names></name><etal/></person-group><article-title>Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2003</year><volume>111</volume><issue>8</issue><fpage>1201</fpage><lpage>1209</lpage><pub-id pub-id-type="doi">10.1172/JCI14172</pub-id><pub-id pub-id-type="other">0037399439</pub-id><?supplied-pmid 12697739?><pub-id pub-id-type="pmid">12697739</pub-id></element-citation></ref><ref id="B42"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Farah</surname><given-names>C.</given-names></name><name><surname>Kleindienst</surname><given-names>A.</given-names></name><name><surname>Bolea</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Exercise-induced cardioprotection: a role for eNOS uncoupling and NO metabolites</article-title><source><italic>Basic Research in Cardiology</italic></source><year>2013</year><volume>108</volume><issue>6</issue><fpage>p. 389</fpage><pub-id pub-id-type="doi">10.1007/s00395-013-0389-2</pub-id><pub-id pub-id-type="other">2-s2.0-84890264223</pub-id><?supplied-pmid 24105420?><pub-id pub-id-type="pmid">24105420</pub-id></element-citation></ref><ref id="B43"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heitzer</surname><given-names>T.</given-names></name><name><surname>Krohn</surname><given-names>K.</given-names></name><name><surname>Albers</surname><given-names>S.</given-names></name><name><surname>Meinertz</surname><given-names>T.</given-names></name></person-group><article-title>Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus</article-title><source><italic>Diabetologia</italic></source><year>2000</year><volume>43</volume><issue>11</issue><fpage>1435</fpage><lpage>1438</lpage><pub-id pub-id-type="doi">10.1007/s001250051551</pub-id><pub-id pub-id-type="other">2-s2.0-0033752910</pub-id><pub-id pub-id-type="other">0033752910</pub-id><?supplied-pmid 11126415?><pub-id pub-id-type="pmid">11126415</pub-id></element-citation></ref><ref id="B44"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takimoto</surname><given-names>E.</given-names></name><name><surname>Champion</surname><given-names>H. C.</given-names></name><name><surname>Li</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Oxidant stress from nitric oxide synthase-3 uncoupling stimulates cardiac pathologic remodeling from chronic pressure load</article-title><source><italic>The Journal of Clinical Investigation</italic></source><year>2005</year><volume>115</volume><issue>5</issue><fpage>1221</fpage><lpage>1231</lpage><pub-id pub-id-type="doi">10.1172/JCI21968</pub-id><pub-id pub-id-type="other">20944445197</pub-id><?supplied-pmid 15841206?><pub-id pub-id-type="pmid">15841206</pub-id></element-citation></ref><ref id="B45"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Upmacis</surname><given-names>R. K.</given-names></name><name><surname>Crabtree</surname><given-names>M. J.</given-names></name><name><surname>Deeb</surname><given-names>R. S.</given-names></name><etal/></person-group><article-title>Profound biopterin oxidation and protein tyrosine nitration in tissues of ApoE-null mice on an atherogenic diet: contribution of inducible nitric oxide synthase</article-title><source><italic>American Journal of Physiology. Heart and Circulatory Physiology</italic></source><year>2007</year><volume>293</volume><issue>5</issue><fpage>H2878</fpage><lpage>H2887</lpage><pub-id pub-id-type="doi">10.1152/ajpheart.01144.2006</pub-id><pub-id pub-id-type="other">2-s2.0-36148975722</pub-id><?supplied-pmid 17766468?><pub-id pub-id-type="pmid">17766468</pub-id></element-citation></ref><ref id="B46"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carnicer</surname><given-names>R.</given-names></name><name><surname>Hale</surname><given-names>A. B.</given-names></name><name><surname>Suffredini</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Cardiomyocyte GTP cyclohydrolase 1 and tetrahydrobiopterin increase NOS1 activity and accelerate myocardial relaxation</article-title><source><italic>Circulation Research</italic></source><year>2012</year><volume>111</volume><issue>6</issue><fpage>718</fpage><lpage>727</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.112.274464</pub-id><pub-id pub-id-type="other">2-s2.0-84865861379</pub-id><pub-id pub-id-type="other">84865861379</pub-id><?supplied-pmid 22798524?><pub-id pub-id-type="pmid">22798524</pub-id></element-citation></ref><ref id="B47"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yaras</surname><given-names>N.</given-names></name><name><surname>Ugur</surname><given-names>M.</given-names></name><name><surname>Ozdemir</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Effects of diabetes on ryanodine receptor ca release channel (RyR2) and Ca<sup>2+</sup> homeostasis in rat heart</article-title><source><italic>Diabetes</italic></source><year>2005</year><volume>54</volume><issue>11</issue><fpage>3082</fpage><lpage>3088</lpage><pub-id pub-id-type="doi">10.2337/diabetes.54.11.3082</pub-id><pub-id pub-id-type="other">2-s2.0-33644677758</pub-id><pub-id pub-id-type="other">33644677758</pub-id><?supplied-pmid 16249429?><pub-id pub-id-type="pmid">16249429</pub-id></element-citation></ref><ref id="B48"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pereira</surname><given-names>L.</given-names></name><name><surname>Matthes</surname><given-names>J.</given-names></name><name><surname>Schuster</surname><given-names>I.</given-names></name><etal/></person-group><article-title>Mechanisms of [Ca<sup>2+</sup>]<sub>i</sub> transient decrease in cardiomyopathy of <italic>db/db</italic> type 2 diabetic mice</article-title><source><italic>Diabetes</italic></source><year>2006</year><volume>55</volume><issue>3</issue><fpage>608</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.2337/diabetes.55.03.06.db05-1284</pub-id><pub-id pub-id-type="other">33644783906</pub-id><?supplied-pmid 16505222?><pub-id pub-id-type="pmid">16505222</pub-id></element-citation></ref><ref id="B49"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>S. M.</given-names></name><name><surname>Wang</surname><given-names>Y. L.</given-names></name><name><surname>Guo</surname><given-names>C. Y.</given-names></name><name><surname>Chen</surname><given-names>J. L.</given-names></name><name><surname>Wu</surname><given-names>Y. Q.</given-names></name></person-group><article-title>Progressive decay of Ca<sup>2+</sup> homeostasis in the development of diabetic cardiomyopathy</article-title><source><italic>Cardiovascular Diabetology</italic></source><year>2014</year><volume>13</volume><issue>1</issue><fpage>p. 75</fpage><pub-id pub-id-type="doi">10.1186/1475-2840-13-75</pub-id><pub-id pub-id-type="other">2-s2.0-84899477535</pub-id><?supplied-pmid 24712865?><pub-id pub-id-type="pmid">24712865</pub-id></element-citation></ref><ref id="B50"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>E.</given-names></name><name><surname>Natali</surname><given-names>A. J.</given-names></name><name><surname>da Silva</surname><given-names>M. F.</given-names></name><etal/></person-group><article-title>Swimming training attenuates the morphological reorganization of the myocardium and local inflammation in the left ventricle of growing rats with untreated experimental diabetes</article-title><source><italic>Pathology, Research and Practice</italic></source><year>2016</year><volume>212</volume><issue>4</issue><fpage>325</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.1016/j.prp.2016.02.005</pub-id><pub-id pub-id-type="other">2-s2.0-84958073294</pub-id><pub-id pub-id-type="other">84958073294</pub-id><?supplied-pmid 26896925?><pub-id pub-id-type="pmid">26896925</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="fig1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>High-intensity training. Maximal time (min) and velocity (km/h) test. Rats were submitted to an exercise test before (control) and after induction of diabetes. Week 0 corresponds to the time point after the confirmation of diabetes. From week 0, the result of each week test was used to calculate the 80% of maximal capacity for the next week training. Then, every week, a maximal capacity test was performed. <sup>&#x02020;&#x02020;&#x02020;</sup><italic>p</italic> &#x0003c; 0.005 versus all the other groups; <sup>&#x02217;&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.005 versus week 0; <sup>&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.001 versus week 0; <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 versus week 0.</p></caption><graphic xlink:href="OMCL2017-7921363.001"/></fig><fig id="fig2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Cardiac hypertrophy induced by diabetes. Cardiac sections were stained with hematoxylin and eosin (see the photomicrographs). The bar graphs depict the statistical analysis for cellular hypertrophy (area and perimeter) in the control (nondiabetic), diabetic, and diabetic&#x02009;+&#x02009;exercise (diabetes EX) rats. The bar indicates 50&#x02009;<italic>&#x003bc;</italic>m. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 versus the other groups; <sup>&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.01 versus control. <italic>N</italic> = 5 hearts in each group.</p></caption><graphic xlink:href="OMCL2017-7921363.002"/></fig><fig id="fig3" orientation="portrait" position="float"><label>Figure 3</label><caption><p>Cardiac fibrosis induced by diabetes. Cardiac sections were stained with Sirius red (see the photomicrographs). The bar graphs depict the statistical analysis for fibrosis in the control (nondiabetic), diabetic, and diabetic&#x02009;+&#x02009;exercise (diabetes EX) rats. <italic>N</italic> = 5 hearts in each group. The scale bar indicates 50&#x02009;<italic>&#x003bc;</italic>m. <sup>&#x02217;&#x02217;</sup><italic>p</italic> &#x0003c; 0.01 versus control.</p></caption><graphic xlink:href="OMCL2017-7921363.003"/></fig><fig id="fig4" orientation="portrait" position="float"><label>Figure 4</label><caption><p>Cardiac apoptosis. Assessment of apoptosis by TUNEL. (a) Photomicrographs (green channel) show the positive nuclei for the TUNEL reaction of the representative cardiac sections from the control (nondiabetic), diabetic, and diabetic&#x02009;+&#x02009;exercise rats, <italic>n</italic> = 5 hearts in each group. (b) Photomicrographs (red channel) show total nuclei of the same sections stained with propidium iodide. (c) Photomicrographs show the merged signal for both channels. The scale bar indicates 10&#x02009;<italic>&#x003bc;</italic>m. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 versus the other groups.</p></caption><graphic xlink:href="OMCL2017-7921363.004"/></fig><fig id="fig5" orientation="portrait" position="float"><label>Figure 5</label><caption><p>NOX2 and NOX4 mRNA expression in diabetic hearts. Quantification for NOX2 and NOX4 mRNA, normalized to the levels of GAPDH, by real-time PCR, from the control (nondiabetic), diabetic, and diabetic&#x02009;+ exercise (diabetic EX) rat hearts; <italic>n</italic> = 3 hearts in each group. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 versus control.</p></caption><graphic xlink:href="OMCL2017-7921363.005"/></fig><fig id="fig6" orientation="portrait" position="float"><label>Figure 6</label><caption><p>NOX proteins expression in diabetic cardiomyopathy. Representative Western blots for NOX2, NOX4, and p67<sup>phox</sup> in the control (nondiabetic), diabetic, and diabetic&#x02009;+&#x02009;exercise (diabetic EX) rat hearts. The bar graphs indicate the densitometry analysis for 5 hearts of each group, normalized by GAPDH levels. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 versus control.</p></caption><graphic xlink:href="OMCL2017-7921363.006"/></fig><fig id="fig7" orientation="portrait" position="float"><label>Figure 7</label><caption><p>eNOS uncoupling in diabetes. (a) Representative Western blot for eNOS as dimer and monomer, and total cardiac eNOS from control (non-diabetic), diabetic and diabetic + exercise rats hearts (diabetic EX), <italic>n</italic> = 5 hearts each group. (b) Quantification for cardiac levels eNOS. (c) Ratio of dimer to monomer eNOS. (d) Intracardiac levels of tetrahydrobiopterin (BH<sub>4</sub>). <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 versus control.</p></caption><graphic xlink:href="OMCL2017-7921363.007"/></fig><fig id="fig8" orientation="portrait" position="float"><label>Figure 8</label><caption><p>Phospholamban phosphorylation and SERCA2 expression. Levels of phospholamban (PLB) phosphorylation in control (non-diabetic), diabetic, and diabetic rats submitted to exercise training (diabetic EX). Representative Western blots for the phosphorylated form of phospholamban at serine 16 (PLB Ser16), total phospholamban (PLB), and SERCA2 from cardiac homogenates. The bar graphs correspond to the densitometry analysis for 5 hearts in each group. <sup>&#x02217;</sup><italic>p</italic> &#x0003c; 0.05 versus control.</p></caption><graphic xlink:href="OMCL2017-7921363.008"/></fig><table-wrap id="tab1" orientation="portrait" position="float"><label>Table 1</label><caption><p>Body weight and plasma glucose.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">Parameters</th><th align="center" rowspan="1" colspan="1">Control</th><th align="center" rowspan="1" colspan="1">Diabetic</th><th align="center" rowspan="1" colspan="1">Diabetic&#x02009;+&#x02009;exercise</th><th align="center" rowspan="1" colspan="1">
<italic>p</italic> value</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Baseline body weight, g</td><td align="center" rowspan="1" colspan="1">307.5&#x02009;&#x000b1;&#x02009;7.5</td><td align="center" rowspan="1" colspan="1">333.0&#x02009;&#x000b1;&#x02009;8.6</td><td align="center" rowspan="1" colspan="1">335.0&#x02009;&#x000b1;&#x02009;10.6</td><td align="center" rowspan="1" colspan="1">0.1258</td></tr><tr><td align="left" rowspan="1" colspan="1">Final body weight, g</td><td align="center" rowspan="1" colspan="1">452.5&#x02009;&#x000b1;&#x02009;19.3</td><td align="center" rowspan="1" colspan="1">318.0&#x02009;&#x000b1;&#x02009;6.2<sup>&#x02020;</sup></td><td align="center" rowspan="1" colspan="1">298.0&#x02009;&#x000b1;&#x02009;26.1<sup>&#x02020;</sup></td><td align="center" rowspan="1" colspan="1">0.0004</td></tr><tr><td align="left" rowspan="1" colspan="1">Baseline plasma glucose (mg/dL)</td><td align="center" rowspan="1" colspan="1">87.0&#x02009;&#x000b1;&#x02009;8.7</td><td align="center" rowspan="1" colspan="1">78.0&#x02009;&#x000b1;&#x02009;2.0</td><td align="center" rowspan="1" colspan="1">100.6&#x02009;&#x000b1;&#x02009;4.5</td><td align="center" rowspan="1" colspan="1">0.0501</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma glucose at the beginning of training (mg/dL)</td><td align="center" rowspan="1" colspan="1">78.7&#x02009;&#x000b1;&#x02009;3.5</td><td align="center" rowspan="1" colspan="1">573.5&#x02009;&#x000b1;&#x02009;44.1<sup>&#x02020;</sup></td><td align="center" rowspan="1" colspan="1">516.6&#x02009;&#x000b1;&#x02009;72.7<sup>&#x02020;</sup></td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr><tr><td align="left" rowspan="1" colspan="1">Plasma glucose at the end of training (mg/dL)</td><td align="center" rowspan="1" colspan="1">108.4&#x02009;&#x000b1;&#x02009;5.8</td><td align="center" rowspan="1" colspan="1">587.9&#x02009;&#x000b1;&#x02009;15.9<sup>&#x02020;</sup></td><td align="center" rowspan="1" colspan="1">476.7&#x02009;&#x000b1;&#x02009;42.6<sup>&#x02020;&#x02020;</sup></td><td align="center" rowspan="1" colspan="1">&#x0003c;0.0001</td></tr></tbody></table><table-wrap-foot><fn><p>
<sup>&#x02020;</sup>
<italic>p</italic> &#x0003c; 0.005 versus control; <sup>&#x02020;&#x02020;</sup><italic>p</italic> &#x0003c; 0.05 versus diabetic.</p></fn></table-wrap-foot></table-wrap></floats-group></article>